Regional health priorities for dementia: a roadmap for the Western Pacific.

Autor:	Timmins HC; Neuroscience Research Australia, Sydney, Australia., Mok VCT; Gerald Choa Neuroscience Institute, Lau Tat Chuen Research Centre of Brain Degenerative Diseases in Chinese, Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China., Kim SH; Department of Neurology, College of Medicine, Hanyang University, Seoul 04763, Republic of Korea., Shahrizaila N; Neurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia., Sung JY; Department of Neurology, School of Medicine, Taipei Medical University, Taiwan., Sobue G; Aichi Medical University, Nagakute, Aichi 480-1195, Japan., Agustini S; Mayapada Hospital, Jakarta Selatan, Indonesia., Ward S; Centre for Healthy Brain Ageing, School of Psychiatry, The University of New South Wales, Sydney, Australia.; Department of Geriatric Medicine, The Prince of Wales Hospital, Sydney, Australia., Anstey KJ; Neuroscience Research Australia, Sydney, Australia.; UNSW Ageing Futures Institute, School of Psychology, University of New South Wales, Sydney, Australia., Talbot DL; Neuroscience Research Australia, Sydney, Australia., Mazumder S; Neuroscience Research Australia, Sydney, Australia., Tu S; Neuroscience Research Australia, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia., Tan RH; Brain and Mind Centre, University of Sydney, Sydney, Australia.; School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Australia., Shin-Yi Lin C; Brain and Mind Centre, University of Sydney, Sydney, Australia.; Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., O'Callaghan C; Brain and Mind Centre, University of Sydney, Sydney, Australia.; School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Australia., Michaelian JC; Brain and Mind Centre, University of Sydney, Sydney, Australia.; Charles Perkins Centre, School of Psychology, Faculty of Science, University of Sydney, NSW, Australia., Jeon YH; Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Foxe D; Brain and Mind Centre, University of Sydney, Sydney, Australia.; School of Psychology, University of Sydney, Sydney, Australia., Naismith SL; Brain and Mind Centre, University of Sydney, Sydney, Australia.; Charles Perkins Centre, School of Psychology, Faculty of Science, University of Sydney, NSW, Australia., Piguet O; Brain and Mind Centre, University of Sydney, Sydney, Australia.; School of Psychology, University of Sydney, Sydney, Australia., Ahmed R; Brain and Mind Centre, University of Sydney, Sydney, Australia.; Memory and Cognition Clinic, Department of Neuroscience, Royal Prince Alfred Hospital, Sydney, Australia., Devenney E; Neuroscience Research Australia, Sydney, Australia.; School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Australia.; Western Sydney Local Health District, Westmead Hospital, Westmead, Sydney, Australia., Park SB; Brain and Mind Centre, University of Sydney, Sydney, Australia.; School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Australia., Kiernan MC; Neuroscience Research Australia, Sydney, Australia.; University of New South Wales, Sydney, Australia.; Department of Neurology, Prince of Wales Hospital, Sydney, Australia.
Jazyk:	angličtina
Zdroj:	The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2024 Sep 16; Vol. 50, pp. 101179. Date of Electronic Publication: 2024 Sep 16 (Print Publication: 2024).
DOI:	10.1016/j.lanwpc.2024.101179
Abstrakt:	In the Western Pacific Region, the prevalence of dementia is expected to increase, however, the diversity of the region is expected to present unique challenges. The region has varying levels of preparedness, with a limited number of countries having a specific national dementia plan and awareness campaigns. Diversity of risk and healthcare services within the region is exerting impact on diagnosis, treatment, care, and support, with most countries being under resourced. Similarly, the ability to monitor dementia-related indicators and progress research, particularly relating to treatment and clinical trial access needs to be addressed. Countries require comprehensive national plans that lay out how resources will be allocated to improve dementia literacy, train, and support carers, mobilise resources to reduce risk factors and improve research capabilities. These plans need to be informed by consumers and tailored to the region to develop an inclusive society for people living with dementia and their families. Competing Interests: ST's research is supported by an NHMRC Ideas Grant (APP2029871), FightMND, and Lenity Australia. SHK was supported by a grant of the Korea Dementia Research Project through the Korea Dementia Research Center (KDRC), funded by the Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea (RS-2024-00348451)”. SW is the Clinical Lead/steering committee co-chair of the ADNeT Registry and received an honorium from ROCHE and Eisai for attendance at an advisory meeting. KJA received a speaker honorarium from Roche in 2023 and is supported by ARC FL19010001. CO is supported by a University of Sydney Robinson Fellowship and an Australian National Health and Medical Research Council EL2 Fellowship (2016866). CSYL is supported by the Sydney Medical School Foundation, University of Sydney. DF is supported by the Edwards Fund for Dementia Research and has received research grants from the Dementia Australia Research Foundation, outside the work submitted. OP is supported in part by an NHMRC Leadership Fellowship and has received research grants from the NHMRC and the Australian Research Council, outside the submitted work. JCM received a speaker honorarium; investigator-initiated research grant to institution from Eisai Australia. Y-HJ has received research grants from the National Health and Medical Research Council (NHMRC) and Arcare in Australia and travel support for invited talks from Singapore Sing Health, Northern Ireland Queen’s University Belfast, Hong Kong Jockey Club, and Korea National Health Insurance Service: Long-term Care, all outside the submitted work. MCK was supported by a NHMRC Practitioner Fellowship (1156093) and National Health and Medical Research Council of Australia Partnership Project (1153439). RHT is supported by a FightMND Mid-Career Fellowship and her research is supported by NSW Health and MNDRA. GS is supported by the Japan Agency for Medical Research and Development. SN received a speaker honorarium HT, SP, DT, SM, SA, VCTM, NS, JYS, have no conflict of interests to declare. (© 2024 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu